Thank you for participating in Biotech Showcase™ 2012!

1,353 attendees from 858 companies participated in 2,012 one-to-one meetings and
240 company presentations on products and technologies.

Impressions of Biotech Showcase ►

Save the date and check back in the coming weeks for information on next year's Biotech Showcase™, January 7–9, in San Fransisco, CA.

Use partnering360^® to:

• Follow up and stay in touch with people you met at Biotech Showcase
• Access an archive of all meeting requests your company has sent and received at any partneringONE event
• See which conferences your contacts will attend next

The Biotech Showcase 2012 partnering site will remain available for at least one year. Meeting requests are no longer being processed.

Log in to your Biotech Showcase 2012 partneringONE^® account ►
View impressions of Biotech Showcase ►
See videos of Biotech Showcase ►

Biotech Showcase™ 2012

Join the connectingSF™ group on partnering360^® to meet up with life science colleagues in San Francisco during the week of January 8, 2012.

Already a member of partnering360? Sign in and join the group.
Not a member? Sign up now for free.

Innovation – Opportunity – Collaboration

Biotech Showcase™ provides private and public life science companies the opportunity to present to an audience of investors and business development executives during the course of the industry's largest annual healthcare investor conference.

Now in its fourth year, Biotech Showcase 2012 is expected to attract upwards of 1,500 attendees. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies. more ►

more ►

Conference videos

Life sciences innovation: The struggle to retain and attract investorsJanuary 11, 2012 | Biotech Showcase™ 2012Panelists address ways to overcome funding obstacles for innovative life science programs and their investors.view "executive recap"     view "full session"

Molecular diagnostics: A sector of increasing importanceJanuary 11, 2012 | Biotech Showcase™ 2012Experienced MDx developers, investors and dealmakers explore challenges and opportunities to be managed.view "executive recap"     view "full session"

Getting a drug approved as the FDA Is evolvingJanuary 11, 2012 | Biotech Showcase™ 2012What to do and how to do it as FDA encourages innovators.view "full session"

Shifting sands: What will drive the next phase of value for the pharma and biotech industries?January 10, 2012 | Biotech Showcase™ 2012How will pharma's shift away from traditional interests affect partnering strategies of emerging biotechs?view "executive recap"     view "full session"

Case study of the AstraZeneca/Rigel partnershipJanuary 10, 2012 | Biotech Showcase™ 2012Dealmakers discuss the partnership between AstraZeneca and Rigel.view "full session"

Alternative financing options for life science companiesJanuary 10, 2012 | Biotech Showcase™ 2012This workshop focuses on the tools an emerging company can use to finance their development.view "executive recap"     view "full session"

The 2nd annual Regenerative Medicine State of the Industry briefingJanuary 10, 2012 | Biotech Showcase™ 2012The Alliance for Regenerative Medicine briefs on current trends in cell therapy and regenerative medicine.view "full session"

Reimbursement: A critical component of valuationJanuary 9, 2012 | Biotech Showcase™ 2012This panel discusses ways to maximize payment amounts under evolving CMS standards for more favorable valuation.view "full session"

Redefining exit options given the current economic climateJanuary 9, 2012 | Biotech Showcase™ 2012Liquidity options, proposed risk reduction deal structures and other exit pathways are discussed.view "full session"

Infectious disease: Fighting the #2 global killerJanuary 9, 2012 | Biotech Showcase™ 2012Biotech companies present promising new approaches against the world's #2 killer.view "executive recap"     view "full session"

Program

The three-day program features multiple tracks of presenting companies, plenary sessions, the opportunity to schedule one-to-one meetings and networking.

Participants

Participants include private and public equity investors, analysts, bankers, biopharmaceutical and life science industry executives and other industry professionals.
Register for Biotech Showcase ►

Industry supporters

The event is presented with the support of a number of regional and national biotechnology associations whose members directly benefit from this opportunity.
Our Supporters ►

Announcement Service

email update@ebdgroup.com
to receive news on this and other EBD Group conferences.